| The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer JL Bishop, D Thaper, S Vahid, A Davies, K Ketola, H Kuruma, R Jama, ... Cancer Discovery 7 (1), 54-71, 2017 | 344 | 2017 |
| Cellular plasticity and the neuroendocrine phenotype in prostate cancer AH Davies, H Beltran, A Zoubeidi Nature Reviews Urology 15 (5), 271-286, 2018 | 332 | 2018 |
| Spatial and temporal expression of the 23 murine Prolactin/Placental Lactogen-related genes is not associated with their position in the locus DG Simmons, S Rawn, A Davies, M Hughes, JC Cross BMC genomics 9 (1), 1-20, 2008 | 235 | 2008 |
| Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance K To, A Fotovati, KM Reipas, JH Law, K Hu, J Wang, A Astanehe, ... Cancer research 70 (7), 2840-2851, 2010 | 206 | 2010 |
| Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells AL Stratford, CJ Fry, C Desilets, AH Davies, YY Cho, Y Li, Z Dong, ... Breast Cancer Research 10 (6), 1-12, 2008 | 170 | 2008 |
| Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells MR Finkbeiner, A Astanehe, K To, A Fotovati, AH Davies, Y Zhao, H Jiang, ... Oncogene 28 (11), 1421-1431, 2009 | 115 | 2009 |
| Biological evolution of castration-resistant prostate cancer A Davies, V Conteduca, A Zoubeidi, H Beltran European urology focus 5 (2), 147-154, 2019 | 93 | 2019 |
| An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer A Davies, S Nouruzi, D Ganguli, T Namekawa, D Thaper, S Linder, ... Nature Cell Biology 23 (9), 1023-1034, 2021 | 83 | 2021 |
| The epigenetic and transcriptional landscape of neuroendocrine prostate cancer A Davies, A Zoubeidi, LA Selth Endocrine-Related Cancer 27 (2), R35-R50, 2020 | 71 | 2020 |
| Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas K Hu, C Lee, D Qiu, A Fotovati, A Davies, S Abu-Ali, D Wai, ER Lawlor, ... Molecular cancer therapeutics 8 (11), 3024-3035, 2009 | 67 | 2009 |
| YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification AH Davies, I Barrett, MR Pambid, K Hu, AL Stratford, S Freeman, ... Oncogene 30 (34), 3649-3660, 2011 | 60 | 2011 |
| Regulation of tumor cell plasticity by the androgen receptor in prostate cancer JL Bishop, A Davies, K Ketola, A Zoubeidi Endocr Relat Cancer 22 (3), R165-R182, 2015 | 59 | 2015 |
| ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer S Nouruzi, D Ganguli, N Tabrizian, M Kobelev, O Sivak, T Namekawa, ... Nature communications 13 (1), 1-15, 2022 | 47 | 2022 |
| Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells AH Davies, K Reipas, K Hu, R Berns, N Firmino, AL Stratford, SE Dunn Oncotarget 6 (24), 20570, 2015 | 44 | 2015 |
| YB‐1 Transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal‐like breast cancer AH Davies, KM Reipas, MR Pambid, R Berns, AL Stratford, A Fotovati, ... Stem cells 32 (6), 1437-1450, 2014 | 43 | 2014 |
| CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer M Ahmed, F Soares, JH Xia, Y Yang, J Li, H Guo, P Su, Y Tian, HJ Lee, ... Nature communications 12 (1), 1-15, 2021 | 36 | 2021 |
| Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition K Ketola, RSN Munuganti, A Davies, KM Nip, JL Bishop, A Zoubeidi Clinical Cancer Research 23 (22), 6923-6933, 2017 | 35 | 2017 |
| Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction. M Eaton, AH Davies, J Devine, X Zhao, DG Simmons, E Maríusdóttir, ... PloS one 15 (1), e0226735, 2020 | 31 | 2020 |
| Patient-derived xenografts: A platform for accelerating translational research in prostate cancer AH Davies, Y Wang, A Zoubeidi Molecular and cellular endocrinology 462, 17-24, 2018 | 30 | 2018 |
| YB-1 drives preneoplastic progression: Insight into opportunities for cancer prevention AH Davies, SE Dunn Oncotarget 2 (5), 401, 2011 | 15 | 2011 |
